FDA Announces Possible Link Between Breast Implants And Cancer
This article was originally published in The Gray Sheet
Executive Summary
In response to data suggesting that breast implants may be associated with a rare form of cancer, FDA plans to work with manufacturers on revised product labeling, the agency announced Jan. 26.